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The method of action of antiperspirants has
been the subject of some controversy. Ichibashi
(1) suggested that they act directly on sweat
gland acini based on his observations of histo-
logical changes produced by formaldehyde.
Rostenberg and Gonzales (2) studied the effect of
malonate ions and felt that they reduced sweating
by inhibiting the enzyme, succinic acid dehydro-
genase. The most widely accepted concept,
suggested by the worh of Shelley and Hurley (3)
and Herrmann and Sulzberger (4) is that an
inflammatory reaction around the sweat duet
and its orifice narrows the pore, thereby inter-
fering with the delivery of sweat to the cutaneous
surface. Previous studies by Richter (5), Darrow
(6), Perry and Mount (7, 8) and others (9) have
substantiated the correlation between sweat
gland activity and the Galvanic Skin Response
(GSR). Measurement of the GSR thus provides a
general method for studying the effects of certain
drugs. The present study was initiated to de-
termine whether some topically applied com-
pounds have a demonstrable effect on sweating
as measured by the GSR. Information obtained
in this way might clarify the question of whether
nntiperspirants act directly or indirectly on
sweat glands.
MATERIAL5 AND METHODs
Instrumentation for recording the GSR level
has been described in previous reports wherein
both palms were compared with the forearms
(7, 8). The only difference in the present studies
was that the skin resistance in each palm was
measured separately. This permitted one palm
to be used for drug testing and the other for
control. The complete circuit for each of the two
palmar measurements required a pair of dee-
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trodes. Au electrode of one pair was placed on
the hypothenar eminence where the substance
to be tested was applied. The corresponding
electrode of the second pair was placed on the
contralateral palm and served as the control
site. The second electrode of each pair completed
the circuit and was placed on the flexor surface
of the forearm distal to the elbow thereby serving
as a neutral electrode site. These two neutral or
indifferent electrodes were connected together
in order to eliminate the effect of differences in
the two forearm resistances on the comparison
being made.
For a given test, the substance to be studied
was rubbed into one of the two palms for a
period of 30 seconds. The other palm was left
untreated. A period of two hours was then
permitted to elapse prior to attachment of the
electrodes to permit time for action of the drug.
Then the electrodes were attached and for the
next 45 minutes a continual record was made of
resistance at the two palms. The assignment of
the active substance to the right or left palm was
made at random and all drugs and placebo were
tested five or more times.
Table 1 shows the distribution of the 89 ex-
periments in this series performed on two sub-
jects (66 in one). Aluminum chloride was tested
32 times in 25 and 33 per cent concentrations
(dissolved in distilled water). The quantities of
each concentration studied included 0.5, 1.0, 2.0
and 4.0 cc. Twenty-one tests were in subject A
with the active agent applied to the right palm
in 10 and the left palm in 11. Subject B had 5
tests on the right palm and 6 on the left. Non-Spi,
which is a commercial deodorant containing
aluminum salts, was tested in 13 different ex-
periments in amounts of 0.5, 1.0, 2.0 and 4.0 cc.
It was applied 5 times to the right palm and 8 to
the left. The Banthine series totaled 29 tests
with dosages ranging from 50—200 mgm. Seven-
teen in subject A included 5 on the right palm
and 12 on the left. Subject B had 12 tests, 5 on
his right palm and 7 on his left. Prantal cream
was tested 9 times and the placebo base 6 times.
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TABLE 1
Distribution of experiments with topical
corn pounds
Cumpound Tested
N ber
es
Numberre
Palm
Number
sjts
Palm
Prantal and Prantal
Base
Banthine
Aluminum Chloride
NonSpi
Totals
15
29
32
13
89
8
10
15
5
38
7
19
17
8
51
They were divided between the right and left
palm, S and 7 respectively.
REdULTS
Based on previous experiments (7, 8) the GSR
level rises following the oral or intramuscular
administration of sweat stimulating drugs and
falls after sweat inhibiting compounds. in the
present tests minor differences in the GSR level
occurred between the test and control sites for
each drug and the placebo. These differences
were in both directions, the GSR level being
higher on some occasions at the test site and on
other occasions at the control site. '[1he over-all
difference tended toward a rise of the GSR level
(equivalent to increased sweating) at the test
site. Under the present experimental conditions
no consistent fall in GSR level was observed
which would be anticipated if the drugs inhibited
sweat gland activity.
DT5OU5SJON
A decrease in axillary sweating following the
use of aluminum salts has been observed by a
number of investigators using various experi-
mental technics such as starch-iodine and quan-
tity of sweat absorbed by a measured amount of
circulating hot air (10, U). Similar conclusions
were drawn by Herrmann et at (12) using brom-
phenol-blue impregnated filter paper squares.
Although this evidence demonstates that alumi-
num salts decrease the amount of sweat on the
surface of the skin, there is no agreement about
how this is accomplished. A review of some of the
past work indicates that antiperspirants may act
either directly or indirectly on the sweat glands.
A possibility of direct action is based on the
histological studies of Ichibashi using formalde-
hyde. One of the indirect explanations is sug-
gested by Rostcnberg and Gonzales (2) who
reported that malonate ions topically applied
decrease sweating by inhibiting the enzyme
succinic acid dehydrogenase. It is also con-
ceivable that antiperspirants might decrease
sweating by direct pharmacological action such
as an anticholinergie effect. However, the most
widely accepted explanation was suggested by
the observations of Shelley and Hurley (3) and
Hcrrmann and Sulzbergcr (4) that antisudorifics
act indirectly by producing an inflammatory
reaction with edema and expansion of the horny
layer at the ductal orifice producing a narrowing
of the pore thereby reducing the amount of
sweat reaching the cutaneous surface.
Both Non-Spi (containing aluminum chloride)
and aluminum chloride (25 and 33 per cent) in
varying quantities up to 4.0 cc had no definitive
effect on the GSR level. In previous reports we
have demonstrated a lowering of the GSR level
following oral or intramuscular administration of
Banthinc or atropinc and a rise in this level after
pilocarpine or mecholyl. Based upon these
observations we might speculate that aluminum
salts should produce a fall in GSR level if they
had a local anhidrotic effect at the glandular
level. Since there is ample clinical evidence that
topical aluminum compounds reduce the amount
of sweat reaching the surface, the absence of
their effect on the GSR level might be construed
as indicating that aluminum compounds reduce
sweating by obstruction of sweat glands rather
than acting at the glandular level. These present
studies have not, however, precluded the chance
that larger concentrations of aluminum salts
might effect the GSR, a possibility that will be
evaluated in future studies.
It is noteworthy that the axillary areas, con-
taining both apocrine and eccrinc glands, have
been the sites of most previous investigations
with antipcrspirants. In the present studies the
palms, which contain only cccrine glands, were
tested. The question of what contribution the
apocrinc glands make might be clarified by
similar GSR experiments in the axilla.
The present series included an evaluation of
topically applied Banthinc and Prantal on the
GSR for several reasons. First, both compounds,
when administered orally, have been shown to
effectively reduce hyperhidrosis as demonstrated
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by Zupko and Prokop (13). This observation has
been correlated with the effects of these two
drugs on the GSR regardless of whether they are
administered orally or parenterally (8). Secondly,
Hirsehmann (14) reported a decrease in sweating
following the topical application of 2 per cent and
5 per cent Prantal in a tale vehicle. However, the
results of the present experiments using 5 per
cent Prantal cream and 50—200 mgm. Banthine
showed no inhibition of sweating indicated by a
decrease in the GSR level. The question whether
higher concentrations or other vehicles would
produce different results by enhancing local
absorption remains to be determined by addi-
tional studies. If preliminary findings with
iontophoresis are substantiated, the questions
regarding the role of concentration and penetra-
tion might be clarified (15).
CONCLUSIONS
Under the present experimental conditions,
aluminum chloride, Non-Spi, Prantal cream and
Banthine had no effect in lowering the GSR
level. This indicates that they did not exert a
direct effect on the sweat glands when applied
topically.
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